For example, the 21‐gene recurrence scores (Oncotype DX Breast Cancer Assay) are utilized as an important indicator to evaluate distant disease recurrence and the benefit of adjuvant chemotherapy in estrogen‐receptor‐positive breast cancer. This evidence concerns the gene ESR1 and breast carcinoma.